Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade

In the last decade, the treatment of non-small cell lung cancer (NSCLC) has been revolutionized by the introduction of immune checkpoint inhibitors (ICI) directed against programmed death protein 1 (PD-1) and its ligand (PD-L1), or cytotoxic T lymphocyte antigen 4 (CTLA-4). In spite of these improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Genova, Carlo, Dellepiane, Chiara, Carrega, Paolo, Sommariva, Sara, Ferlazzo, Guido, Pronzato, Paolo, Gangemi, Rosaria, Filaci, Gilberto, Coco, Simona, Croce, Michela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777268/
https://www.ncbi.nlm.nih.gov/pubmed/35069581
http://dx.doi.org/10.3389/fimmu.2021.799455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777268/
https://www.ncbi.nlm.nih.gov/pubmed/35069581
http://dx.doi.org/10.3389/fimmu.2021.799455

Ejemplares similares